Asheville asthma project outcomes positive
Patients in the Asheville Project for asthma had improved outcomes over five years, including fewer ER visits and hospitalizations, according to researchers. In addition to better clinical outcomes through pharmacist interventions, annual direct cost savings averaged $725 per patient and annual indirect cost savings were estimated at $1,230 per patient, including less absenteeism.
Asheville asthma project outcomes positive
Patients in the Asheville Project for asthma had improved outcomes over five years, including fewer ER visits and hospitalizations, according to researchers. In addition to better clinical outcomes through pharmacist interventions, annual direct cost savings averaged $725 per patient and annual indirect cost savings were estimated at $1,230 per patient, including less absenteeism.
To see more Hot off the Press news articles, click here http://www.drugtopics.com/Hot+off+the+Press.
FDA’s Recent Exemptions: What Do They Mean as We Finalize DSCSA Implementation?
October 31st 2024Kala Shankle, Vice President of Regulatory Affairs with the Healthcare Distribution Alliance, and Ilisa Bernstein, President of Bernstein Rx Solutions, LLC, discussed recent developments regarding the Drug Supply Chain Security Act.
